Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Humacyte
4373
Humacyte
Health Care
Technology
Biotechnology
Medical
Medical Devices
Humacyte uses proprietary technology to grow stable, offtheshelf human tissuereplacements such as vein grafts to predesigned clinical and commercial specifications..
Suggest edits
Type
B2c
Raised
$302.8M
Follow us
Companies in the same industry
Apollo Endosurgery
Premier Research
Inspire Medical Systems
BrainScope Company
TRACON Pharmaceuticals
Avro Life Science
Hemex Health
BioFab
AxioMed, LLC
CureWize
Alexa global traffic share
Overview
Funding
5
Add info
Latest funding
Show all
$74,999,980
Venture capital (Series C) - 2018
$18,000,000
Venture capital - 2017
California Institute for Regenerative Medicine
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
Pulse 2.0
Humacyte Stock (HUMA): Why The Price Fell
$10,000,000
Venture capital
Cary, Morrisville, Apex, Holly Springs, Raleigh, Fuquay Varina , Triangle, Durham, Real Estate Blog
RTP's Humacyte gets $10M from California stem cell group
Xconomy
California Agency Awards Humacyte $9.9M for Blood Vessel Technology
Health
Science
Funding
$150,000,000
Venture capital (Series B)
Xconomy
Humacyte Lands $150M Series B for Phase 3 Study of Lab-Grown Veins
Health
Science
